Mustang Bio to sell Massachusetts CAR-T manufacturing facility
The CAR-T-centered biotech Mustang Bio is selling off its manufacturing facility in Massachusetts for $11 million.
Mustang Bio announced on Thursday that it will be selling its 27,000-square-foot manufacturing and analytical testing facility in Worcester, MA, to cell and gene therapy CDMO uBriGene Biosciences. Per the terms of the deal, uBriGene will make a $6 million upfront payment, with the other $5 million payable upon Mustang raising $10 million from equity raises once the transaction closes.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.